Category Archives: Transhuman News

Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers  Scientific American

More here:
Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers - Scientific American

How oxytocin drives connections of newly integrated adult-born neurons: Research  Hindustan Times

Read this article:
How oxytocin drives connections of newly integrated adult-born neurons: Research - Hindustan Times

Many people wonder if Alzheimers disease runs in the family. A persons chance of having the disease may be higher if he or she has certain genes passed down from a parent. However, having a parent with Alzheimers does not always mean that someone will develop it.

Each human cell contains the instructions a cell needs to do its job. These instructions are made up of DNA (deoxyribonucleic acid), which is packed tightly into structures called chromosomes. Each chromosome has thousands of segments called genes.

Genes are passed down from a person's biological parents. They carry information that defines traits such as eye color and height. Genes also play a role in keeping the body's cells healthy.

Problems with geneseven small changes to a genecan cause diseases like Alzheimer's.

Genetic mutations (permanent change in one or more specific genes) can cause diseases. If a person inherits a genetic mutation that causes a certain disease, then he or she will usually get the disease. Sickle cell anemia, cystic fibrosis, and some cases of early-onset Alzheimer's disease are examples of inherited genetic disorders.

Other changes or differences in genes, called genetic variants, may increase or decrease a person's risk of developing a particular disease. When a genetic variant increases disease risk but does not directly cause a disease, it is called a genetic risk factor.

Identifying genetic variants may help researchers find the most effective ways to treat or prevent diseases such as Alzheimer's in an individual. This approach, called precision medicine, takes into account individual variability in genes, environment, and lifestyle for each person.

The expression of geneswhen they are switched on or offcan be affected, positively and negatively, by environmental and lifestyle factors, such as exercise, diet, chemicals, or smoking. The field of epigenetics is studying how such factors can alter a cell's DNA in ways that affect gene activity.

There are two types of Alzheimer'searly-onset and late-onset. Both types have a genetic component.

Most people with Alzheimer's have the late-onset form of the disease, in which symptoms become apparent in their mid-60s and later.

Researchers have not found a specific gene that directly causes late-onset Alzheimer's disease. However, having a genetic variant of the apolipoprotein E (APOE) gene on chromosome 19 does increase a person's risk. The APOE gene is involved in making a protein that helps carry cholesterol and other types of fat in the bloodstream.

APOE comes in several different forms, or alleles. Each person inherits two APOE alleles, one from each biological parent.

APOE 4 is called a risk-factor gene because it increases a person's risk of developing the disease. However, inheriting an APOE 4 allele does not mean that a person will definitely develop Alzheimer's. Some people with an APOE 4 allele never get the disease, and others who develop Alzheimer's do not have any APOE 4 alleles.

Recent research indicates that rare forms of the APOE allele may provide protection against Alzheimers disease. More studies are needed to determine how these variations might delay disease onset or lower a persons risk.

Early-onset Alzheimers disease is rare, representing less than 10 percent of all people with Alzheimers. It typically occurs between a persons 30s and mid-60s. Some cases are caused by an inherited change in one of three genes.

The three single-gene mutations associated with early-onset Alzheimers disease are:

Mutations in these genes result in the production of abnormal proteins that are associated with the disease. Each of these mutations plays a role in the breakdown of APP, a protein whose precise function is not yet fully understood. This breakdown is part of a process that generates harmful forms of amyloid plaques, a hallmark of Alzheimers disease.

A child whose biological mother or father carries a genetic mutation for one of these three genes has a 50/50 chance of inheriting that mutation. If the mutation is in fact inherited, the child has a very strong probability of developing early-onset Alzheimers disease.

For other cases of early-onset Alzheimers, research has shown that other genetic components are involved. Studies are ongoing to identify additional genetic risk variants.

Having Down syndrome increases the risk of developing early-onset Alzheimers disease. Many people with Down syndrome develop Alzheimers as they get older, with symptoms appearing in their 50s or 60s. Researchers believe this is because people with Down syndrome are born with an extra copy of chromosome 21, which carries the APP gene.

For more information, see NIA's Early-Onset Alzheimer's Disease: A Resource List.

A blood test can identify which APOE alleles a person has, but results cannot predict who will or will not develop Alzheimer's disease. Currently, APOE testing is used primarily in research settings to identify study participants who may have an increased risk of developing Alzheimer's. This knowledge helps scientists look for early brain changes in participants and compare the effectiveness of possible treatments for people with different APOE profiles.

Genetic testing is also used by physicians to help diagnose early-onset Alzheimers disease and to test people with a strong family history of Alzheimers or a related brain disease.

Genetic testing for APOE or other genetic variants cannot determine an individuals likelihood of developing Alzheimers diseasejust which risk factor genes a person has. It is unlikely that genetic testing will ever be able to predict the disease with 100 percent accuracy, researchers believe, because too many other factors may influence its development and progression.

Some people learn their APOE status through consumer genetic testing or think about getting this kind of test. They may wish to consult a doctor or genetic counselor to better understand this type of test and their test results. General information about genetic testing can be found at:

Discovering all that we can about the role of Alzheimer's disease genetic risk and protective factors is an important area of research. NIA supports several major genetics research programs. Understanding more about the genetic basis of the disease will help researchers to:

NIA Alzheimers and related Dementias Education and Referral (ADEAR) Center800-438-4380adear@nia.nih.govwww.nia.nih.gov/alzheimersThe NIA ADEAR Center offers information and free print publications about Alzheimers and related dementias for families, caregivers, and health professionals. ADEAR Center staff answer telephone, email, and written requests and make referrals to local and national resources.

This content is provided by the NIH National Institute on Aging (NIA). NIA scientists and other experts review this content to ensure it is accurate and up to date.

Content reviewed: December 24, 2019

See the original post here:
Alzheimer's Disease Genetics Fact Sheet - National Institute on Aging